| |
| |
|
| Insider
Information: |
Prange Karen |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
173,701 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$8,640,627 |
|
|
|
Indirect Value
|
$74,650 |
|
|
| Total
Shares |
174,701 |
|
|
| Total
Value |
$8,715,277 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 75.9%
|
 -228.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP&Pres, Uro & Pelvic... |
2016-03-08 |
38,395 |
2016-03-08 |
1,000 |
Premium* |
|
|
Henry Schein Inc |
HSIC |
EVP&CEO Gl.AH.Med.Den.... |
2018-03-02 |
62,902 |
2016-06-10 |
0 |
Premium* |
|
|
Atricure, Inc. |
ATRC |
Director |
2024-05-13 |
23,928 |
2019-12-04 |
0 |
Premium* |
|
|
Nevro Corp |
NVRO |
|
2023-05-25 |
14,779 |
2019-12-17 |
0 |
Premium* |
|
|
Cantel Medical Corp |
CMN |
Director |
2021-06-02 |
0 |
2020-07-31 |
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director |
2023-07-21 |
8,799 |
2021-07-01 |
0 |
Premium* |
|
|
Embecta Corp. |
EMBC |
Director |
2024-02-07 |
24,898 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRAY |
Viewray, Inc. |
Director |
– • – |
2023-07-19 |
4 |
S |
$0.08 |
$6,890 |
D/D |
(91,866) |
46,399 |
0 |
% |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
138,265 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2022-05-10 |
4 |
B |
$2.66 |
$100,002 |
D/D |
37,600 |
83,754 |
2.39 |
% |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2023-07-21 |
4 |
S |
$0.05 |
$1,918 |
D/D |
(37,600) |
8,799 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
37,212 |
60,859 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,395 |
46,154 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2013-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
25,862 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2014-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
45,602 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2015-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
43,292 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2014-12-10 |
4 |
AS |
$12.64 |
$249,607 |
D/D |
(19,753) |
17,430 |
0 |
- |
|
| HSIC |
Henry Schein Inc |
EVP&CEO Gl.AH.Med.Den.Sur.Grp |
• – – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,558 |
62,902 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,866 |
36,296 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2015-07-07 |
4 |
AS |
$17.66 |
$308,308 |
D/D |
(17,456) |
17,430 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-03-08 |
4 |
AS |
$17.27 |
$254,749 |
D/D |
(14,747) |
38,395 |
0 |
- |
|
| HSIC |
Henry Schein Inc |
EVP&CEO Gl.AH.Med.Den.Sur.Grp |
• – – |
2016-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,895 |
12,895 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-02-22 |
4 |
D |
$17.26 |
$208,742 |
D/D |
(12,094) |
48,765 |
0 |
- |
|
| EMBC |
Embecta Corp. |
Director |
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,455 |
24,898 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2013-07-02 |
4 |
D |
$9.17 |
$77,321 |
D/D |
(8,432) |
17,430 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2014-07-02 |
4 |
D |
$13.13 |
$110,541 |
D/D |
(8,419) |
37,183 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Womens Health |
• • – |
2015-07-02 |
4 |
D |
$17.57 |
$147,693 |
D/D |
(8,406) |
34,886 |
0 |
- |
|
| ATRC |
Atricure, Inc. |
Director |
– • – |
2024-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,788 |
23,928 |
0 |
- |
|
| EMBC |
Embecta Corp. |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,069 |
0 |
- |
|
| NVRO |
Nevro Corp |
|
• • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,754 |
14,779 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-01-01 |
4 |
D |
$18.44 |
$118,625 |
D/D |
(6,433) |
29,863 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP&Pres, Uro & Pelvic Health |
• • – |
2016-02-08 |
4 |
S |
$16.05 |
$99,785 |
D/D |
(6,216) |
23,647 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
